| Application no. and date | 05759527.4 (espacenet) (Federated) (European Patent Register), 20050610 | | Patent/reg. no. and date | DK/EP 1765292, 20171004 | | Publication date | 20070328 | | Priority no. and date | US 579191 P, 20040612 | | EP pub. no. and date |
EP 1765292 20070328 | | Effective date | | | Applicant/owner | Collegium Pharmaceutical, Inc., 400 Highland Corporate Drive
Cumberland, RI 02864, US | | Applicant ref. no. | P63171DK01 | | Inventor | HIRSH, Jane, 15 Peirce Road
Wellesley, MA 02581, US,
RARIY, Roman, V., 245 Kelton Street, Apartment 42
Allston, MA 02134, US,
FLEMING, Alison, B., 39 Sumner Street, 1
North Attleboro, MA 02760, US,
KLIBANOV, Alexander, M., 85 East India Row, Apartment 23A
Boston, MA 02110, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 9/14 (2006.01) , A61K 9/20 (2006.01) | | Title | MISBRUGS-FOREBYGGENDE LÆGEMIDDELFORMULERINGER | | Int. application no. | US2005020588 | | Int. publication no. | WO2005123039 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
